Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

09.10.2017

2 Am J Surg
2 Anticancer Res
1 BMC Cancer
2 Br J Cancer
4 Cancer
1 Clin Cancer Res
2 Dig Dis
1 Gastroenterology
1 Gut
3 Hum Pathol
1 Int J Cancer
1 J Nucl Med
1 J Pathol
2 Oncogene
10 PLoS One
2 World J Surg



    Am J Surg

  1. PARK JH, Ishizuka M, McSorley ST, Kubota K, et al
    Staging the tumor and staging the host: A two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer.
    Am J Surg. 2017 Sep 20. pii: S0002-9610(17)31190.
    >> Share

  2. HARUKI K, Shiba H, Horiuchi T, Sakamoto T, et al
    Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases.
    Am J Surg. 2017;214:752-756.
    >> Share


    Anticancer Res

  3. TAKIYAMA A, Tanaka T, Yamamoto Y, Hata K, et al
    Microsatellite Status of Primary Colorectal Cancer Predicts the Incidence of Postoperative Colorectal Neoplasms.
    Anticancer Res. 2017;37:5785-5790.
    >> Share

  4. BAKALOVA R, Zhelev Z, Shibata S, Nikolova B, et al
    Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic" Versus "Onco-Suppressive" Reactive Oxygen Species.
    Anticancer Res. 2017;37:5449-5458.
    >> Share


    BMC Cancer

  5. YEDID N, Kalma Y, Malcov M, Amit A, et al
    The effect of a germline mutation in the APC gene on beta-catenin in human embryonic stem cells.
    BMC Cancer. 2016;16:952.
    >> Share


    Br J Cancer

  6. GAYARRE J, Martin-Gimeno P, Osorio A, Paumard B, et al
    Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.
    Br J Cancer. 2017;117:1048-1062.
    >> Share

  7. SHINOZAKI E, Yoshino T, Yamazaki K, Muro K, et al
    Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensi
    Br J Cancer. 2017 Oct 3. doi: 10.1038/bjc.2017.
    >> Share


    Cancer

  8. SADETZKI S, Chetrit A, Freedman LS, Hakak N, et al
    Cancer risk among Holocaust survivors in Israel-A nationwide study.
    Cancer. 2017;123:3335-3345.
    >> Share

  9. PRINTZ C
    Some stage III colon cancer patients may need only half of the standard chemotherapy course.
    Cancer. 2017;123:3871.
    >> Share

  10. HONG YR, Tauscher J, Cardel M
    Distrust in health care and cultural factors are associated with uptake of colorectal cancer screening in Hispanic and Asian Americans.
    Cancer. 2017 Oct 4. doi: 10.1002/cncr.31052.
    >> Share

  11. SEGNAN N, Armaroli P
    Early detection versus prevention in colorectal cancer screening: Methods estimates and public health implications.
    Cancer. 2017 Oct 4. doi: 10.1002/cncr.31032.
    >> Share


    Clin Cancer Res

  12. BOCCACCIO C, Luraghi P, Bigatto V, Cipriano E, et al
    A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy.
    Clin Cancer Res. 2017 Oct 3. pii: clincanres.2151.2017.
    >> Share


    Dig Dis

  13. COEBERGH VAN DEN BRAAK RRJ, Lalmahomed ZS, Buttner S, Hansen BE, et al
    Nonphysician Clinicians in the Follow-Up of Resected Patients with Colorectal Cancer.
    Dig Dis. 2017;36.
    >> Share

  14. SOREIDE K
    Task-Shifting in Surveillance after Surgery for Colorectal Cancer: Addressing the Right Question?
    Dig Dis. 2017;36:15-16.
    >> Share


    Gastroenterology

  15. NABER SK, Kuntz KM, Henrikson NB, Williams MS, et al
    Cost Effectiveness of Age-specific Screening Intervals for People with Family Histories of Colorectal Cancer.
    Gastroenterology. 2017 Sep 27. pii: S0016-5085(17)36180.
    >> Share


    Gut

  16. BARAULT L, Amatu A, Siravegna G, Ponzetti A, et al
    Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Gut. 2017 Oct 5. pii: gutjnl-2016-313372. doi: 10.1136/gutjnl-2016-313372.
    >> Share


    Hum Pathol

  17. KOJIMA M, Shimazaki H, Iwaya K, Nakamura T, et al
    Intramucosal colorectal carcinoma with invasion of the lamina propria: a study by the Japanese Society for Cancer of the Colon and Rectum.
    Hum Pathol. 2017;66:230-237.
    >> Share

  18. COATES RF, Gardner JA, Gao Y, Cortright VM, et al
    Significance of positive and inhibitory regulators in the TGF-beta signaling pathway in colorectal cancers.
    Hum Pathol. 2017;66:34-39.
    >> Share

  19. JANG S, Hong M, Shin MK, Kim BC, et al
    KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
    Hum Pathol. 2017;65:21-30.
    >> Share


    Int J Cancer

  20. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Secombe KR, et al
    Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.
    Int J Cancer. 2017;140:2820-2829.
    >> Share


    J Nucl Med

  21. HOUARD C, Pinaquy JB, Henriques DE Figueiredo B, Mesguich C, et al
    Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in post-treatment evaluation of anal carcinoma.
    J Nucl Med. 2017 Mar 9. pii: jnumed.116.185280. doi: 10.2967/jnumed.116.185280.
    >> Share


    J Pathol

  22. BINDER H, Hopp L, Schweiger MR, Hoffmann S, et al
    Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome.
    J Pathol. 2017;243:242-254.
    >> Share


    Oncogene

  23. MA X, Meng Z, Jin L, Xiao Z, et al
    CAMK2gamma in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation.
    Oncogene. 2017;36:4060-4071.
    >> Share

  24. HARDBOWER DM, Coburn LA, Asim M, Singh K, et al
    EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis.
    Oncogene. 2017;36:3807-3819.
    >> Share


    PLoS One

  25. LI P, Xiao Z, Braciak TA, Ou Q, et al
    Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.
    PLoS One. 2017;12:e0181615.
    >> Share

  26. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    >> Share

  27. MURPHY C, Rettedal E, Lehouritis P, Devoy C, et al
    Intratumoural production of TNFalpha by bacteria mediates cancer therapy.
    PLoS One. 2017;12:e0180034.
    >> Share

  28. RIVA A, BOrgesen M, Guldmann-Christensen M, Hauge Kyneb M, et al
    SensiScreen(R)KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
    PLoS One. 2017;12:e0178027.
    >> Share

  29. TSENG JC, Narayanan N, Ho G, Groves K, et al
    Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    PLoS One. 2017;12:e0182689.
    >> Share

  30. MORUZZI S, Guarini P, Udali S, Ruzzenente A, et al
    One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.
    PLoS One. 2017;12:e0185792.
    >> Share

  31. LIN GL, Ting HJ, Tseng TC, Juang V, et al
    Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    PLoS One. 2017;12:e0185625.
    >> Share

  32. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2017;12:e0185778.
    >> Share

  33. BLAGOEV KB, Wilkerson J, Burotto M, Kim C, et al
    Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status.
    PLoS One. 2017;12:e0175484.
    >> Share

  34. SINN DH, Min YW, Son HJ, Rhee PL, et al
    Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma.
    PLoS One. 2017;12:e0179480.
    >> Share


    World J Surg

  35. OHTAKI Y, Shimizu K, Nagashima T, Nakazawa S, et al
    Clinical and Radiological Discrimination of Solitary Pulmonary Lesions in Colorectal Cancer Patients.
    World J Surg. 2017 Oct 5. doi: 10.1007/s00268-017-4243.
    >> Share

  36. VENARA A, Duchalais E, Dariel A, Aubert P, et al
    Anti-inflammatory Effects of Enhanced Recovery Programs on Early-Stage Colorectal Cancer Surgery.
    World J Surg. 2017 Oct 5. doi: 10.1007/s00268-017-4266.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016